Ming Proschitsky

Ming Proschitsky has worked in the biotechnology industry since 2011. Ming began their career as a Research Scientist at NeuroPhage Pharmaceuticals, Inc. in 2011. In 2014, they were promoted to Senior Scientist at NeuroPhage Pharmaceuticals / Proclara Biosciences. In 2018, they were promoted again to Principal Scientist at Proclara Biosciences. In 2019, they moved to Pandion Therapeutics as Principal Scientist, Therapeutic Protein Technologies. Currently, they are the Head of BioTherapeutics at Walden Biosciences.

Ming Proschitsky attended Tsinghua University from 1999 to 2003, where they received a B.S. in Biological Science. Ming then attended Boston University School of Medicine from 2004 to 2010. No additional certifications were listed.